Earnings ·
Park Ha Biological Technology reported unaudited financial results for the six months ended April 30, 2026
PHHPark Ha Biological Technology Co., Ltd.
Park Ha Biological Technology reported unaudited financial results for the six months ended April 30, 2026. Total revenue reached $1,257,689, a 1% increase from $1,239,197 in the prior year period, driven by a 77% rise in product sales to non-franchisees. However, franchise fee revenue fell 35% to $541,584 due to a reduction in the number of franchisees from 39 to 21. The company reported a net loss of $918,282, significantly improved from a $19,835,994 net loss in the same period of 2025. This improvement was largely due to a massive decrease in general and administrative expenses, which dropped from $20,632,549 to $1,189,274 following the absence of a large share-based payment expense. The company operates in the beauty industry, developing and selling skincare products through direct sales and franchise alliances.